Itera | $12,000,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Protuoso Biosciences
United States
- San Francisco
- 28/05/2026
- Seed
- $9,500,000
Protuoso Biosciences is pioneering innovative multifunctional biologics to address complex diseases with high unmet need. At the core of its platform are MUXBODIES, fully recombinant fusion proteins that integrate multiple modalities to engage a combination of disease mechanisms. Leveraging AI-enabled protein engineering, computational protein design, and massively parallel synthetic biology, Protuoso discovers and develops first-in-class and best-in-class therapies across cardiometabolic, oncology and autoimmune indications. The company operates under a scalable therapeutic-agnostic hub-and-spoke model, building and optimizing its core protein engineering platform at the hub while advancing therapeutic area-focused assets through disciplined execution and early business development engagement at each spoke. For more information, visit www.protuoso.bio.
- Industry Biotechnology Research
- Website https://www.protuoso.bio/
- LinkedIn https://www.linkedin.com/company/protuoso-bio/
Fields Good | $1,800,000 | (May 28, 2026)
Cypher AI | $2,000,000 | (May 28, 2026)
NavigateAI | $25,000,000 | (May 27, 2026)
Go Swag | $5,000,000 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
OpenRouter | $113,000,000 | (May 27, 2026)